Portuguese research SME specialising in phytochemical nanomaterials for neurodegeneration and materials-based energy systems via MSCA-RISE networks.
CASCATACHUVA LDA is a small Portuguese private company based in Almada that participates in EU-funded research consortia as an industry partner, contributing applied expertise in materials science and bioactive compounds. Their involvement spans two distinct research domains: energy-harvesting systems based on adsorption of atmospheric humidity, and phytochemical nanomaterials targeting the prevention of Alzheimer's and Parkinson's diseases. Both engagements were under the MSCA-RISE scheme, meaning the company actively participates in international researcher exchanges — hosting visiting scientists and sending staff to academic partner institutions. With very limited public data available, their precise commercial activities remain unclear, but their project portfolio suggests a research-active SME operating at the intersection of materials science and applied biomedical chemistry.
PhytoAPP (2021–2026) focuses on water-soluble phytomaterial inhibitors targeting amyloid fibrils associated with Alzheimer's and Parkinson's diseases, with in vitro and in vivo toxicity testing.
PhytoAPP keywords include bioactivity, kinetics, in vitro testing, and in vivo testing, suggesting hands-on involvement in preclinical evaluation workflows.
PhytoAPP explicitly lists nanomaterials and materials design as keyword areas, indicating engagement with the formulation or characterisation side of the research.
SSHARE (2019–2023) targeted a self-sufficient radiant adsorption system for converting atmospheric humidity into electricity toward net-zero energy goals.
Both projects used the MSCA-RISE funding scheme, placing the company in a recurring role as an industry host and sender of researchers across international academic networks.
CASCATACHUVA's earliest H2020 engagement (SSHARE, from 2019) was in the energy domain — specifically atmospheric water harvesting and adsorption-based electricity generation — with very sparse keyword data suggesting a peripheral or administrative role in that project. Their second and more recent project (PhytoAPP, from 2021) reveals a substantive shift toward biomedical materials science: phytochemicals, nanomaterials, amyloid inhibition, and preclinical toxicology testing. The trend is a move away from clean energy engineering toward health-focused nanomaterials and bioactive compound research, though the two projects are too few to confirm a deliberate strategic pivot.
CASCATACHUVA appears to be deepening its footprint in health-relevant nanomaterials and phytochemistry, making them a more plausible future partner for biomedical or nutraceutical research consortia than for energy or engineering projects.
CASCATACHUVA has participated in EU projects exclusively as a consortium member — never as a coordinator — across both of its H2020 engagements. They have worked within large, internationally distributed consortia: 16 unique partners spread across 12 countries from just two projects, which is a high partner density for this project count. This pattern is typical of MSCA-RISE participants who join broad research networks rather than anchor them, making them a flexible and low-friction addition to a consortium rather than a project driver.
Despite only two projects, CASCATACHUVA has built connections with 16 distinct partner organisations across 12 countries, pointing to genuinely international research consortia rather than regional clusters. Their network is geographically diverse but shallow — no repeated partners are visible from this data.
CASCATACHUVA occupies an unusual niche as a Portuguese private-sector SME that participates in highly academic MSCA-RISE projects, bridging industrial application and fundamental research in two quite different fields. What distinguishes them is their apparent willingness to engage across topic boundaries — energy systems and neurodegenerative disease prevention — which may reflect a broad materials science competence or a flexible research services model. For consortium builders needing an industry partner in Portugal with MSCA-RISE experience and some biomedical materials background, they represent a rare and accessible option in a geography where such SME partners are scarce.
